Danielle A. Eekman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Danielle A. Eekman has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Irene E. M. Bultink
Department of Rheumatology and Clinical Immunology, Amsterdam UMC, Amsterdam, Netherlands
3 shared publications - Ben Ac Dijkmans
Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands
2 shared publications W. F. Lems
VU Medical Center
2 shared publications- Willem Frederik Lems
Department of Rheumatology, Amsterdam UMC, Amsterdam, The Netherlands
2 shared publications A. M. Huisman
Sint Franciscus Gasthuis
1 shared publication- Annemieke C. Heijboer
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC, University of Amsterdam , Amsterdam
1 shared publication
Latest Publications
- 27 September 2013
- Published by Springer Nature in Osteoporosis International
- Vol. 25 (1) , 195-204
Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation
- 27 September 2013
- Published by Springer Nature in Osteoporosis International
- Vol. 25 (1) , 195-204
Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation
- 13 September 2013
- Published by Springer Nature in Osteoporosis International
- Vol. 25 (2) , 701-709
Optimizing fracture prevention: the fracture liaison service, an observational study
The response rate to the invitation to the fracture liaison service and reasons for non-response were evaluated in 2,207 fragility fracture patients. Fifty-one percent responded; non-responders were most often not interested (38 %) or were hip fracture patients. After 1 year of treatment, 88 % was still persistent and 2 % had a new fracture.
- 13 September 2013
- Published by Springer Nature in Osteoporosis International
- Vol. 25 (2) , 701-709
Optimizing fracture prevention: the fracture liaison service, an observational study
The response rate to the invitation to the fracture liaison service and reasons for non-response were evaluated in 2,207 fragility fracture patients. Fifty-one percent responded; non-responders were most often not interested (38 %) or were hip fracture patients. After 1 year of treatment, 88 % was still persistent and 2 % had a new fracture.
- Open Access
- 6 December 2012
- Published by Springer Nature
Implementation of a strategy of osteoporosis screening in patients over 50 years of age with a first fracture
- 6 December 2012
- Published by Springer Nature
Open AccessImplementation of a strategy of osteoporosis screening in patients over 50 years of age with a first fracture
- Open Access
- 21 July 2011
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 12 (1) , 167
Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
Monitoring osteoporosis therapy by measurement of bone turnover markers (BTMs) might detect non-compliance in an earlier stage of anti-osteoporosis treatment and improve persistence.
- 21 July 2011
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 12 (1) , 167
Open AccessBone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
Monitoring osteoporosis therapy by measurement of bone turnover markers (BTMs) might detect non-compliance in an earlier stage of anti-osteoporosis treatment and improve persistence.
- Open Access
- 15 July 2009
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 10 (1) , 86
Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
In case of contraindications or intolerance during treatment with oral bisphosphonates (OB), administration of pamidronate intravenously is a widely used alternative.
- 15 July 2009
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 10 (1) , 86
Open AccessTreatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
In case of contraindications or intolerance during treatment with oral bisphosphonates (OB), administration of pamidronate intravenously is a widely used alternative.